Comparison of neutralizing antibody responses against SARS‐CoV‐2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?

Lignende værker

• Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine
  af: Gavriatopoulou, Maria, et al.
  Udgivet: (2021)
• Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine
  af: Terpos, Evangelos, et al.
  Udgivet: (2021)
• High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
  af: Terpos, Evangelos, et al.
  Udgivet: (2021)
• Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
  af: Terpos, Evangelos, et al.
  Udgivet: (2021)
• Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis
  af: Kastritis, Efstathios, et al.
  Udgivet: (2021)